A price slash for Coach (COH) may have investors thinking twice before picking up the handbag maker stock. Credit Suisse (CS) lowered its price target for Coach to $30 per share from $39 due to future sales. The firm is keeping its Neutral rating for the stock. But a brighter outlook for a glaucoma drug maker, Aerie Pharmaceuticals (AERI). Canaccord initiated coverage of the drugmaker with a buy rating and a price target set at $40 per share. And Jefferies is raising its price target for Toyota Motors (TM) to $139.80 per share. The firm is also reiterating its BUY rating for the stock. TheStreet's Susannah Lee has the details in today's Analysts' Actions from Wall Street.

If you liked this article you might like

Canada Goose CEO: The Whole Year Has Been Exhilarating

Canada Goose CEO: The Whole Year Has Been Exhilarating

A Surprising Retail 'Must-Own' Stock for 2018

A Surprising Retail 'Must-Own' Stock for 2018

My Surprising 'Must-Own' Stock for 2018

My Surprising 'Must-Own' Stock for 2018

Is Abercrombie & Fitch Back Just in Time for Black Friday?

Is Abercrombie & Fitch Back Just in Time for Black Friday?

Goldman Sachs Signals an Amazing 2018

Goldman Sachs Signals an Amazing 2018